On ECHEMI
Home > Drugs > influenza
influenza
Influenza (abbreviated as flu) is an acute respiratory infectious disease caused by influenza virus. It is also a highly contagious and fast-spreading disease. The pathogen is influenza virus type A, B, and C, which is transmitted through droplets. The typical symptoms are usually as follows: sudden and rapid high fever, fatigue, body muscle aches and mild respiratory symptoms. The course of the disease is short and self-limiting. Middle-aged people and patients with chronic respiratory diseases or heart disease are prone to pneumonia. The most significant characteristics of influenza in epidemiology are: sudden outbreak, rapid spread, wide coverage, and certain seasonality (epidemics in northern my country generally occur in winter, while in the south they occur more in summer and winter). The recently popular influenza B is a type of influenza. Compared with the other two strains, it has little variation and is less likely to spread. In previous years, influenza B was mostly prevalent during the transition from spring to summer in May and June, and the symptoms were not obvious. This year, it broke out after the beginning of winter, which is a special phenomenon. Monitoring from November to December showed that 89% of influenza in Guangdong was influenza B. There are two strains of influenza B. The most common strain in the past was the Victoria strain, which is also the vaccine strain recommended by the World Health Organization this year. However, the influenza B strain that has appeared recently is the Yamagata strain, which is less common and is caused by the limited protection of the vaccine. Students should pay attention to personal hygiene, wash their hands frequently, open windows for ventilation, and go to the hospital for treatment in time if they find influenza symptoms such as fever, cough, and body aches.
Related Drugs
Compound sulfamethoxazole injection
Indication: In recent years, many common clinical pathogens are often resistant to this product, so it is necessary to refer to the drug sensitivity results when treating bacterial infections. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, it can be used in patients with a history of at least one attack of Pneumocystis carinii, or H
Manufacturer:

Shanghai Xudong Haipu Pharmaceutical Co., Ltd.

Compound sulfamethoxazole injection
Indication: In recent years, many common clinical pathogens are often resistant to this product, so it is necessary to refer to the drug sensitivity results when treating bacterial infections. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, it can be used in patients with a history of at least one attack of Pneumocystis carinii, or H
Manufacturer:

Shanghai Xudong Haipu Pharmaceutical Co., Ltd.

Compound sulfamethoxazole injection
Indication: In recent years, many common clinical pathogens are often resistant to this product, so it is necessary to refer to the drug sensitivity results when treating bacterial infections. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, it can be used in patients with a history of at least one attack of Pneumocystis carinii, or H
Manufacturer:

Shanghai Xudong Haipu Pharmaceutical Co., Ltd.

Compound sulfamethoxazole injection
Indication: In recent years, many common clinical pathogens are often resistant to this product, so it is necessary to refer to the drug sensitivity results when treating bacterial infections. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, it can be used in patients with a history of at least one attack of Pneumocystis carinii, or H
Manufacturer:

Shanghai Xudong Haipu Pharmaceutical Co., Ltd.

Amoxicillin Sodium for Injection
Indication: Amoxicillin is suitable for patients with the following infections caused by sensitive bacteria (non-β-lactamase-producing strains) who are in severe condition and need hospitalization or cannot take oral medication. 1 Upper respiratory tract infections such as otitis media, sinusitis, pharyngitis, tonsillitis, etc. caused by hemolytic streptococci, streptococci pneumoniae, staphylococci or Haemophilus influenzae. 2 Urogenital tract infections caused by Escherichia coli, Proteus mirabilis or Enterococcus faecalis. 3 Skin and soft tissue infections caused by hemolytic streptococci, staphylococci or Escherichia coli. 4 Lower respiratory tract infections such as acute bronchitis and pneumonia caused by hemolytic streptococci, streptococci pneumoniae, staphylococci or Haemophilus influenzae. 5nbs
Manufacturer:

Hunan Tiansheng Pharmaceutical Co., Ltd.

Amoxicillin Sodium for Injection
Indication: Amoxicillin is suitable for patients with the following infections caused by sensitive bacteria (non-β-lactamase-producing strains) who are in severe condition and need hospitalization or cannot take oral medication. 1 Upper respiratory tract infections such as otitis media, sinusitis, pharyngitis, tonsillitis, etc. caused by hemolytic streptococci, streptococci pneumoniae, staphylococci or Haemophilus influenzae. 2 Urogenital tract infections caused by Escherichia coli, Proteus mirabilis or Enterococcus faecalis. 3 Skin and soft tissue infections caused by hemolytic streptococci, staphylococci or Escherichia coli. 4 Lower respiratory tract infections such as acute bronchitis and pneumonia caused by hemolytic streptococci, streptococci pneumoniae, staphylococci or Haemophilus influenzae. 5nbs
Manufacturer:

Gansu Lanyao Pharmaceutical Co., Ltd.

Amoxicillin Sodium for Injection
Indication: Amoxicillin is suitable for patients with the following infections caused by sensitive bacteria (non-β-lactamase-producing strains) who are in severe condition and need hospitalization or cannot take oral medication. 1 Upper respiratory tract infections such as otitis media, sinusitis, pharyngitis, tonsillitis, etc. caused by hemolytic streptococci, streptococci pneumoniae, staphylococci or Haemophilus influenzae. 2 Urogenital tract infections caused by Escherichia coli, Proteus mirabilis or Enterococcus faecalis. 3 Skin and soft tissue infections caused by hemolytic streptococci, staphylococci or Escherichia coli. 4 Lower respiratory tract infections such as acute bronchitis and pneumonia caused by hemolytic streptococci, streptococci pneumoniae, staphylococci or Haemophilus influenzae. 5nbs
Amoxicillin Sodium for Injection
Indication: Amoxicillin is suitable for patients with the following infections caused by sensitive bacteria (non-β-lactamase-producing strains) who are in severe condition and need hospitalization or cannot take oral medication. 1 Upper respiratory tract infections such as otitis media, sinusitis, pharyngitis, tonsillitis, etc. caused by hemolytic streptococci, streptococci pneumoniae, staphylococci or Haemophilus influenzae. 2 Urogenital tract infections caused by Escherichia coli, Proteus mirabilis or Enterococcus faecalis. 3 Skin and soft tissue infections caused by hemolytic streptococci, staphylococci or Escherichia coli. 4 Lower respiratory tract infections such as acute bronchitis and pneumonia caused by hemolytic streptococci, streptococci pneumoniae, staphylococci or Haemophilus influenzae. 5nbs
Manufacturer:

Qingzhou Yaowang Pharmaceutical Co., Ltd.

Isatis root granules
Manufacturer:

Yunnan Mingding Pharmaceutical Co., Ltd.

Compound sulfamethoxazole granules
Indication: 1. For the treatment of urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella; 2. For the treatment of acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae; 3. For the treatment of acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae; 4. For the treatment of intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei; 5. For the treatment of Pneumocystis carinii pneumonia, this product is the first choice; 6. For the prevention of Pneumocystis carinii pneumonia, existing Pneumocystis carinii can be used
Manufacturer:

Furen Pharmaceutical Group Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.